HC Wainwright & Co. Maintains Buy on Affimed, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a Buy rating on Affimed (NASDAQ:AFMD) and raises the price target from $5 to $10.

April 01, 2024 | 10:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Affimed's price target was raised from $5 to $10 by HC Wainwright & Co., maintaining a Buy rating.
The increase in price target by a reputable analyst firm like HC Wainwright & Co. typically signals a strong bullish outlook on the stock, suggesting a potential upside. This is based on the analyst's research and positive evaluation of Affimed's prospects, which could lead to increased investor confidence and a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100